Buckfire and Buckfire 1-800-606-1717
Call Now To Speak With
Michigan's Best Birth Injury Lawyers

Use of botulinum toxin A in management of children with cerebral palsy.

Authors: Friedman BC, Goldman RD Abstract Question What is the role of intramuscular botulinum toxin injections in the management of spasticity and related morbidity in children with cerebral palsy? Answer When botulinum toxin A is injected into the limbs of children with spastic paresis, it induces temporary reduction in muscle tone. It also promotes better motor function when used in combination with conservative treatments such as physiotherapy. Although there is a growing body of evidence for its effective and safe treatment, there is still a lack of consensus on dose, treatment regimens, and the best integration with other clinical modalities. PMID: 21918142 [PubMed - in process] (Source: Canadian Family Physician Medecin de Famille Canadien)

MedWorm Sponsor Message: Please support the DoctorsInChains.org campaign for the health workers in Bahrain. #FreeDoctors

Long-term neurodevelopmental outcome in monochorionic twins after fetal therapy

Abstract: Monochorionic (MC) twins are at risk for several disorders, including twin–twin transfusion syndrome (TTTS), Twin Reverse Arterial Perfusion (TRAP) and selective intrauterine growth restriction (sIUGR). Several fetal interventions, such as serial amnioreduction (AR), fetoscopic laser coagulation of placental anastomoses (FLC) and selective feticide have lead to improved perinatal morbidity and mortality rates. Nevertheless, the rate of cerebral lesions in MC twins after fetal therapy appears to be high. Follow-up studies show a high incidence of cerebral palsy (CP) and neurodevelopmental impairment (NDI). We performed a systematic review on the long-term neurodevelopmental outcome in MC twins with TTTS following AR and FLC and MC twins following selective feticide of the co-twi...

Dopa-responsive Dystonia with a Novel Initiation Codon Mutation in the GCH1 Gene Misdiagnosed as Cerebral Palsy.

Authors: Lee JH, Ki CS, Kim DS, Cho JW, Park KP, Kim S Abstract Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset dystonia and a dramatic response to relatively low doses of levodopa. However, patients with DRD can be misdiagnosed as cerebral palsy or spastic diplegia due to phenotypic variation. Here we report a young woman with DRD who were severely disabled and misdiagnosed as cerebral palsy for over 10 yr. A small dose of levodopa restored wheelchair-bound state to normality. However, thoracolumbar scoliosis has remained as a sequel due to late detection of DRD. Genetic analysis by using PCR-direct sequencing revealed a novel initiation codon mutation (c.1A>T; p.Met1Leu) in GTP cyclohydrolase 1 (GCH1) gene. Although it is known that DRD c...

Long-term neurodevelopmental outcome in monochorionic twins after fetal therapy

Abstract: Monochorionic (MC) twins are at risk for several disorders, including twin–twin transfusion syndrome (TTTS), Twin Reverse Arterial Perfusion (TRAP) and selective intrauterine growth restriction (sIUGR). Several fetal interventions, such as serial amnioreduction (AR), fetoscopic laser coagulation of placental anastomoses (FLC) and selective feticide have lead to improved perinatal morbidity and mortality rates. Nevertheless, the rate of cerebral lesions in MC twins after fetal therapy appears to be high. Follow-up studies show a high incidence of cerebral palsy (CP) and neurodevelopmental impairment (NDI). We performed a systematic review on the long-term neurodevelopmental outcome in MC twins with TTTS following AR and FLC and MC twins following selective feticide of the co-twi...

Neuroprotective Approaches: Before and After Delivery

This article reviews and discusses potential antenatal and postnatal neuroprotective approaches targeted at the numerous risk factors associated with cerebral palsy among preterm infants, including magnesium sulfate. (Source: Clinics in Perinatology)
Next Page »